Physician

Baiju Malde, MD

According to 2025 Medicare claims, Baiju Malde, MD (NPI: 1457338907) practices allergy/immunology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is NORTHWESTERN MEDICAL FACULTY FOUNDATION (NPI: 1346235314; TIN: 363097297) and primary practice location at 60611-2027. Malde is affiliated with the Northwestern Medicine Physician Network ACO (ACO ID: A2620), participating under the MSSP model.

Malde's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 174 traditional Medicare patients, billed 752 HCPCS/CPT codes, and received $24,676 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 1,063 prescription claims across 198 beneficiaries totaling $261,855 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 158 claims. Open Payments data shows 2 records totaling $40. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $78,457 to $261,855. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $0 to $4,870.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	150	1,285	$29,107
2016	178	1,361	$32,385
2017	188	2,102	$37,144
2018	197	1,805	$34,183
2019	213	1,955	$35,594
2020	179	1,434	$25,186
2021	203	1,345	$28,121
2022	188	1,179	$25,557
2023	184	1,086	$27,370
2024	174	752	$24,676

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	105	518	$78,457
2016	122	661	$111,422
2017	145	770	$134,872
2018	159	902	$176,694
2019	165	928	$184,182
2020	175	1,065	$275,109
2021	197	1,028	$313,549
2022	203	1,096	$329,556
2023	189	994	$320,497
2024	198	1,063	$261,855

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	32	$55,195
2018	N/R	26	$36,591
2019	N/R	22	$30,006
2020	N/R	125	$103,824
2021	N/R	132	$121,309
2022	N/R	96	$122,658
2023	N/R	173	$218,296
2024	N/R	158	$203,944

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	16	16	$111
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	57	73	$86
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	43	43	$77
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	95	123	$71
94010	Test to measure expiratory airflow and volume	38	44	$18

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	37	1,470	$29,749
Advair Hfa	Fluticasone Propion/Salmeterol	36	1,950	$22,202
Arnuity Ellipta	Fluticasone Furoate	54	2,460	$19,443
Symbicort	Budesonide/Formoterol Fumarate	40	2,040	$15,767
Breo Ellipta	Fluticasone/Vilanterol	21	1,110	$14,440

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J1559	Injection, immune globulin (hizentra), 100 mg	N	N/R	37	$126,176
J1555	Injection, immune globulin (cuvitru), 100 mg	N	N/R	13	$69,193
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	50	$4,116
Q2052	Services, supplies and accessories used in the home for the administration of intravenous immune globulin (ivig)	N	N/R	12	$3,956
K0552	Supplies for external non-insulin drug infusion pump, syringe type cartridge, sterile, each	N	N/R	46	$504

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$40	Kedrion Biopharma, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Baiju Malde, MD?

Tedicare shows public-source Medicare data for Baiju Malde, MD (NPI 1457338907), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Baiju Malde, MD have ACO affiliation data?

Baiju Malde, MD is shown with ACO affiliation data for Northwestern Medicine Physician Network ACO (MSSP, ACO ID A2620).

What billing organization is linked to Baiju Malde, MD?

Baiju Malde, MD is linked to NORTHWESTERN MEDICAL FACULTY FOUNDATION (billing NPI 1346235314) in the available physician profile data.

Does Baiju Malde, MD have Open Payments data?

Baiju Malde, MD has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.